Cassano, V.; Tallarico, M.; Armentaro, G.; De Sarro, C.; Iannone, M.; Leo, A.; Citraro, R.; Russo, E.; De Sarro, G.; Hribal, M.L.;
et al. Ranolazine Attenuates Brain Inflammation in a Rat Model of Type 2 Diabetes. Int. J. Mol. Sci. 2022, 23, 16160.
https://doi.org/10.3390/ijms232416160
AMA Style
Cassano V, Tallarico M, Armentaro G, De Sarro C, Iannone M, Leo A, Citraro R, Russo E, De Sarro G, Hribal ML,
et al. Ranolazine Attenuates Brain Inflammation in a Rat Model of Type 2 Diabetes. International Journal of Molecular Sciences. 2022; 23(24):16160.
https://doi.org/10.3390/ijms232416160
Chicago/Turabian Style
Cassano, Velia, Martina Tallarico, Giuseppe Armentaro, Caterina De Sarro, Michelangelo Iannone, Antonio Leo, Rita Citraro, Emilio Russo, Giovambattista De Sarro, Marta Letizia Hribal,
and et al. 2022. "Ranolazine Attenuates Brain Inflammation in a Rat Model of Type 2 Diabetes" International Journal of Molecular Sciences 23, no. 24: 16160.
https://doi.org/10.3390/ijms232416160
APA Style
Cassano, V., Tallarico, M., Armentaro, G., De Sarro, C., Iannone, M., Leo, A., Citraro, R., Russo, E., De Sarro, G., Hribal, M. L., & Sciacqua, A.
(2022). Ranolazine Attenuates Brain Inflammation in a Rat Model of Type 2 Diabetes. International Journal of Molecular Sciences, 23(24), 16160.
https://doi.org/10.3390/ijms232416160